Infection Control Market

The global infection control market is witnessing strong and sustained growth due to the increasing number of surgical and clinical procedures, rising prevalence of hospital-acquired infections (HAIs), and growing emphasis on patient safety across healthcare facilities. The global infection control market size is valued at USD 55.3 billion in 2025 and is estimated to reach USD 99.64 billion by 2034, growing at a CAGR of 6.8% during the forecast period (2026–2034).

Infection control encompasses a broad range of products, technologies, and protocols designed to prevent the transmission of infectious diseases in hospitals, clinics, diagnostic laboratories, ambulatory surgical centers, and long-term care facilities. These solutions include sterilization equipment, disinfectants, personal protective equipment (PPE), medical waste management systems, and advanced monitoring technologies. As healthcare providers continue prioritizing infection prevention and regulatory compliance, demand for comprehensive infection control solutions is expected to rise steadily worldwide.

For detailed market insights, growth forecasts, and competitive analysis, visit:

https://straitsresearch.com/report/infection-control-market

Market Drivers

Rising Number of Surgical and Clinical Procedures

The increasing volume of surgical procedures worldwide is one of the primary factors driving the infection control market. Hospitals perform millions of orthopedic, cardiovascular, neurological, cosmetic, and minimally invasive surgeries each year, all of which require strict sterilization protocols to minimize the risk of postoperative infections.

Healthcare facilities are continuously investing in advanced sterilization systems, disinfectants, and infection prevention technologies to ensure patient safety and comply with stringent healthcare standards.

Growing Incidence of Hospital-Acquired Infections (HAIs)

Hospital-acquired infections remain a significant challenge for healthcare systems globally. Patients undergoing surgery, intensive care treatment, dialysis, or long-term hospitalization face increased exposure to infectious pathogens. This has encouraged hospitals to strengthen infection prevention programs through improved hygiene practices, environmental disinfection, and advanced sterilization technologies.

The growing awareness regarding HAIs continues to support long-term market expansion.

Stringent Healthcare Regulations

Governments and healthcare regulatory agencies have introduced rigorous infection prevention guidelines for hospitals, laboratories, and medical device manufacturers. Compliance with international sterilization standards and infection control protocols has become essential for healthcare providers.

Continuous regulatory oversight is encouraging healthcare institutions to upgrade infection control infrastructure.

Market Challenges

High Cost of Advanced Sterilization Systems

Modern sterilization equipment, automated disinfection technologies, and infection surveillance systems require significant capital investment. Small healthcare facilities and clinics may face financial challenges in adopting advanced infection control solutions.

Manufacturers are increasingly developing cost-effective technologies to improve accessibility.

Antimicrobial Resistance

The growing prevalence of antimicrobial-resistant microorganisms presents ongoing challenges for infection prevention strategies. Healthcare providers must continuously adopt new disinfection methods and advanced sterilization technologies to combat evolving pathogens.

Continuous research and product innovation remain essential for effective infection control.

Market Segmentation

By Product

The market is segmented into sterilization equipment, disinfectants, personal protective equipment (PPE), endoscope reprocessing equipment, medical waste disposal systems, and infection surveillance solutions. Sterilization equipment accounts for the largest market share due to its critical role in preventing healthcare-associated infections.

Disinfectants and PPE continue witnessing strong demand across healthcare facilities.

By End User

Major end users include hospitals, ambulatory surgical centers, diagnostic laboratories, pharmaceutical companies, medical device manufacturers, clinics, and long-term care facilities. Hospitals dominate the market due to the large volume of surgeries and patient admissions requiring stringent infection prevention measures.

Ambulatory surgical centers are expected to experience significant growth during the forecast period.

By Application

Applications include surgical instrument sterilization, environmental surface disinfection, hand hygiene, medical device reprocessing, healthcare waste management, and infection surveillance. Surgical instrument sterilization remains the largest application segment owing to increasing surgical procedure volumes globally.

Environmental disinfection technologies continue gaining importance across healthcare environments.

Regional Insights

North America

North America dominates the infection control market due to advanced healthcare infrastructure, strict infection prevention regulations, increasing surgical procedures, and widespread adoption of advanced sterilization technologies. The United States remains the leading regional market.

Europe

Europe represents a significant market supported by robust healthcare systems, increasing healthcare expenditure, and growing awareness regarding hospital-acquired infection prevention. Germany, France, the United Kingdom, Italy, and Spain remain key contributors.

Asia-Pacific

Asia-Pacific is expected to witness the fastest growth during the forecast period. Expanding healthcare infrastructure, increasing hospital construction, rising surgical volumes, and improving infection prevention awareness are driving market growth across China, India, Japan, South Korea, and Southeast Asia.

Government investments in healthcare modernization continue supporting regional expansion.

Latin America, Middle East & Africa

These regions are gradually strengthening healthcare infrastructure through increased public and private investments. Growing healthcare access and expanding infection prevention initiatives are expected to create substantial market opportunities over the coming years.

Key Players Analysis

The infection control market is highly competitive, with leading companies focusing on advanced sterilization systems, automated disinfection technologies, smart infection surveillance platforms, and environmentally sustainable infection prevention products. Companies continue investing in research and development, strategic acquisitions, and global expansion to strengthen their competitive positions.

Artificial intelligence, ultraviolet (UV-C) disinfection, hydrogen peroxide vapor systems, robotic sterilization technologies, and digital infection monitoring platforms are expected to shape the future of infection control.

Key Companies

3M Company
STERIS plc
Getinge AB
Advanced Sterilization Products (Fortive)
Ecolab Inc.
Cantel Medical Corporation
Belimed AG
MMM Group
Matachana Group
Sotera Health Company

Conclusion

The global infection control market is expected to witness sustained growth through 2034, driven by increasing surgical procedures, rising concerns regarding hospital-acquired infections, expanding healthcare infrastructure, and stringent regulatory requirements. Although high equipment costs and antimicrobial resistance remain significant challenges, continuous advancements in sterilization technologies, automated disinfection systems, and infection surveillance solutions are expected to create substantial growth opportunities. As healthcare providers continue prioritizing patient safety and infection prevention, the infection control market will remain a vital component of modern healthcare delivery.

About Us

Straits Research is a leading market research and intelligence organization specializing in research, analytics, and advisory services. The company provides comprehensive market reports, industry insights, and strategic business intelligence across multiple industries, helping organizations identify growth opportunities and make informed business decisions.

Contact Us

Email: [email protected]

Tel: +1 646 905 0080 (U.S.)

Tel: +44 203 695 0070 (U.K.)